Contaminated or underdosed peptides pose real risks, while mislabeled products may contain entirely different substances
At ATX Infusion and Wellness, we offer personalized care grounded in science and safety
A number of studies presented on Friday at the European Society of Cardiology conference found that the pricey drug, which was initially marketed as a diabetes treatment, reduced inflammation regardless of whether users lost weight, The Times of London reported
Koska J, Sands M, Burciu C, DSouza KM, Raravikar K, Liu J, Truran S, Franco DA, Schwartz EA, Schwenke DC, et al
a clinical trial examining dapagliflozin and epicardial adipose tissue is ongoing (NCT02235298)
Patterns and costs associated with glucagon-like peptide-1 receptor agonist use in US adults with type 2 diabetes